1stOncology

BioSeeker Group, established in 1999, is a leading innovator in oncology intelligence, dedicated to enhancing cancer drug development and patient care. With offices in Stockholm, Sweden, and Boston, MA, the company supports stakeholders globally with its award-winning 1stOncology platform, which provides actionable insights into cancer therapeutics. The platform integrates comprehensive data assets enriched by artificial intelligence and machine learning, enabling drug developers to identify new opportunities in the dynamic field of oncology.

BioSeeker's offerings include 1stOncology™, a premier drug intelligence solution, and 1stOncologyCare™, a unified digital decision support tool designed for cancer treatment teams to assess treatment options tailored to patient-specific tumor characteristics and history. With over two decades of experience and a diverse network of experts, BioSeeker collaborates with some of the world's largest pharmaceutical companies, fostering long-term partnerships. By leveraging cutting-edge technology and expert knowledge, BioSeeker is committed to advancing oncology research and improving patient outcomes in cancer care.